Gili et al. initiated a prospective observational study which aimed to describe treatment prescribing patterns in PsA over the first 2 years of follow-up. They also evaluated if the treatment patterns in PsA are in any way conditioned by the age of onset of the disease.
A total of 46 patients with at least 2 years of follow-up within the PsArT (Psoriatic arthritis Age-related Treatment patterns) study were included in the study. These were patients who were diagnosed with early (symptom duration <52 weeks) PsA. Twenty-four of them were female, mean age was 49 with range 16-90 years, and mean disease duration was 20 weeks (range 1-52). This group was divided into Adult-Onset (AOPsA) (age <60 years) and Late-Onset (LOPsA) (onset age ≥60 years) PsA according to the age at the onset of musculoskeletal manifestations. Data were collected at the time of enrollment (baseline), at 12 months, and at 24 months.
It was found that those patients who had LOPsA (n=15) when ...
please login to read the entire article:
You need to register to read the entire article, please do so now.
« Low Bone Mineral Density Is Common in Axial Spondyloarthritis; More Awareness Required Next Article
miRNA-146A Plays Key Role in Bone Metabolism and Osteoporosis »
Table of Contents: EULAR 2018
Psoriasis and Psoriatic Arthritis
Osteoporosis and Osteoarthritis
Systemic Sclerosis and Systemic Lupus Erythematosus
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.